<doc>
  <docmeta id="113hr1801ih">
    <bill congress="113" type="hr" number="1801" version="ih"/>
    <revision size="17404" annotations="0" status="complete" id="4" commit-time="2013-05-20T23:14:31Z" committer="mbohmer" doc="113hr1801ih/4.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H0A565D39F13341AB800F1A103ACA1B2D" public-private="public">
	<metadata>
<dublinCore>
<title>113 HR 1801 IH: Cancer Drug Coverage Parity Act of 2013</title>
<publisher>U.S. House of Representatives</publisher>
<date>2013-04-26</date>
<format>text/xml</format>
<language>EN</language>
<rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>H. R. 1801</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20130426">April 26, 2013</action-date>
			<action-desc>
        <sponsor name-id="H001038">Mr. Higgins</sponsor> (for
			 himself, <cosponsor name-id="M001160">Ms. Moore</cosponsor>,
			 <cosponsor name-id="P000597">Ms. Pingree of Maine</cosponsor>,
			 <cosponsor name-id="C001084">Mr. Cicilline</cosponsor>,
			 <cosponsor name-id="C001036">Mrs. Capps</cosponsor>,
			 <cosponsor name-id="G000551">Mr. Grijalva</cosponsor>,
			 <cosponsor name-id="W000808">Ms. Wilson of Florida</cosponsor>,
			 <cosponsor name-id="H000324">Mr. Hastings of Florida</cosponsor>,
			 <cosponsor name-id="K000210">Mr. King of New York</cosponsor>,
			 <cosponsor name-id="R000053">Mr. Rangel</cosponsor>,
			 <cosponsor name-id="L000560">Mr. Larsen of Washington</cosponsor>,
			 <cosponsor name-id="M000312">Mr. McGovern</cosponsor>,
			 <cosponsor name-id="P000608">Mr. Peters of California</cosponsor>,
			 <cosponsor name-id="W000672">Mr. Wolf</cosponsor>, <cosponsor name-id="M000933">Mr. Moran</cosponsor>, and <cosponsor name-id="F000030">Mr.
			 Farr</cosponsor>) introduced the following bill; which was referred to the
			 <committee-name committee-id="HIF00">Committee on Energy and
			 Commerce</committee-name>, and in addition to the Committees on
			 <committee-name committee-id="HWM00">Ways and Means</committee-name> and
			 <committee-name committee-id="HED00">Education and the
			 Workforce</committee-name>, for a period to be subsequently determined by the
			 Speaker, in each case for consideration of such provisions as fall within the
			 jurisdiction of the committee concerned</action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To amend the Employee Retirement Income Security Act of
		  1974, the Public Health Service Act, and the Internal Revenue Code of 1986 to
		  require group and individual health insurance coverage and group health plans
		  to provide for coverage of oral anticancer drugs on terms no less favorable
		  than the coverage provided for anticancer medications administered by a health
		  care provider.</official-title>
	</form>
	<legis-body id="H5C3547A9E221483FA7912C2603D964B0" style="OLC">
		<section id="H2E32C286449042428E8183052E6BA6E6" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the
			 <quote>
          <short-title>Cancer Drug Coverage Parity Act of
			 2013</short-title>
        </quote>.</text>
		</section>
    <section id="HE1703CE9667A40B9915D5B24158322DD">
      <enum>2.</enum>
      <header>Parity in
			 coverage for oral anticancer drugs</header>
			<subsection id="H996849631CAE469088A8AEFC37FEA381">
        <enum>(a)</enum>
        <header>Employee
			 Retirement Income Security Act of 1974 amendments</header>
        <paragraph commented="no" display-inline="yes-display-inline" id="HB1AD2E8CD0F8496491234A021D4655FC">
          <enum>(1)</enum>
          <text>
            <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Employee Retirement Income Security Act of 1974/t:I/st:B/pt:7/spt:B">Subpart B of part 7 of
			 subtitle B of title I of the Employee Retirement Income Security Act of 1974</cato:entity-ref> is
			 amended by adding at the end the following new section:</text>
					<quoted-block display-inline="no-display-inline" id="H3637BE9A718B4686BCECDA1E41E4EFA9" style="OLC">
						<section id="H5D9FD111F0C04B98A18FA0F410FF63CE">
              <enum>716.</enum>
              <header>Parity in
				coverage for oral anticancer drugs</header>
							<subsection id="HC0A848A4DAEF4FC0B1C8CF99DDFBFBDD">
                <enum>(a)</enum>
                <header>In
				general</header>
                <text display-inline="yes-display-inline">Subject to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Employee Retirement Income Security Act of 1974/s:716/ss:b" proposed="true">subsection
				(b)</cato:entity-ref>, a group health plan, and a health insurance issuer providing health
				insurance coverage in connection with a group health plan, that provides
				benefits with respect to anticancer medications administered by a health care
				provider shall provide for no less favorable coverage for prescribed,
				patient-administered anticancer medications that are used to kill, slow, or
				prevent the growth of cancerous cells and that have been approved by the Food
				and Drug Administration.</text>
							</subsection>
              <subsection commented="no" id="HF2DE46DF47EE404688C415988804691A">
                <enum>(b)</enum>
                <header>Limitation</header>
                <text>
                  <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Employee Retirement Income Security Act of 1974/s:716/ss:a" proposed="true">Subsection
				(a)</cato:entity-ref> shall only apply to an anticancer medication that is prescribed based on a
				finding by the treating physician that the medication—</text>
								<paragraph commented="no" id="H3256B041E04B4034A12EAE8BEEB1528E">
                  <enum>(1)</enum>
                  <text>is medically
				necessary for the purpose of killing, slowing, or preventing the growth of
				cancerous cells; or</text>
								</paragraph>
                <paragraph commented="no" id="H753CBE56031F4EF08B23170079FF4261">
                  <enum>(2)</enum>
                  <text>is clinically
				appropriate in terms of type, frequency, extent site, and duration.</text>
								</paragraph>
              </subsection>
              <subsection id="HB2B28A98B069422AA892CCF19838B447">
                <enum>(c)</enum>
                <header>Application of
				cost-Sharing and restrictions</header>
								<paragraph id="H1D93C2C39F8B43709857CD3CDDCC4AF3">
                  <enum>(1)</enum>
                  <header>In
				general</header>
                  <text>The coverage of anticancer medication under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Employee Retirement Income Security Act of 1974/s:716/ss:a" proposed="true">subsection
				(a)</cato:entity-ref> may be subject to annual deductibles and coinsurance or copayments so long
				as such deductibles, coinsurance, and copayments do not exceed the deductibles,
				coinsurance, and copayments that are applicable to anticancer medications
				administered by a health care provider under the plan or coverage for the same
				purpose.</text>
								</paragraph>
                <paragraph commented="no" id="HB41761FB504F4EFAAD525A264A4FE686">
                  <enum>(2)</enum>
                  <header>Restriction</header>
                  <text display-inline="yes-display-inline">A group health plan or health insurance
				issuer may not, in order to comply with the requirement of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Employee Retirement Income Security Act of 1974/s:716/ss:a" proposed="true">subsection
				(a)</cato:entity-ref>—</text>
									<subparagraph commented="no" id="H550B46F01E4546B1BD7BAE0D1BEF7607">
                    <enum>(A)</enum>
                    <text>impose an increase
				in out-of-pocket costs with respect to anticancer medications;</text>
									</subparagraph>
                  <subparagraph commented="no" id="HF8B36D8D02B246D9841C18EEB43BB602">
                    <enum>(B)</enum>
                    <text display-inline="yes-display-inline">reclassify benefits with respect to
				anticancer medications; or</text>
									</subparagraph>
                  <subparagraph id="H98F9BEB3FCFF41FA9D69C02BEF15F731">
                    <enum>(C)</enum>
                    <text>apply more
				restrictive limitations on prescribed orally-administered anticancer
				medications or intravenously administered or injected anticancer
				medications.</text>
									</subparagraph>
                </paragraph>
              </subsection>
              <subsection id="H2668E4BE3583479B93BDCBDAC2EFE481">
                <enum>(d)</enum>
                <header>Application of
				notice, prohibitions, etc</header>
                <text>The provisions of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Employee Retirement Income Security Act of 1974/s:713/ss:b">subsections (b)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Employee Retirement Income Security Act of 1974/s:713/ss:c">(c)</cato:entity-ref>,
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Employee Retirement Income Security Act of 1974/s:713/ss:d">(d)</cato:entity-ref>, and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Employee Retirement Income Security Act of 1974/s:713/ss:e/p:2">(e)(2) of section 713</cato:entity-ref> shall apply with respect to the coverage
				required by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Employee Retirement Income Security Act of 1974/s:716/ss:a" proposed="true">subsection (a)</cato:entity-ref> in the same manner as they apply with respect to the
				coverage required under such section, except that January 1, 2014, shall be
				substituted for the date referred to in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Employee Retirement Income Security Act of 1974/s:716/ss:b/p:3" proposed="true">subsection (b)(3) of such
				section</cato:entity-ref>.</text>
							</subsection>
              <subsection id="H96383291B5BD40CDA7CB3C021A9FA45E">
                <enum>(e)</enum>
                <header>Construction</header>
                <text>Nothing
				in this section shall be construed—</text>
								<paragraph id="HF11967F9A5CF48348DEAD4635DA6E1C7">
                  <enum>(1)</enum>
                  <text display-inline="yes-display-inline">to require the use of orally-administered
				anticancer medications as a replacement for other anticancer medications;
				or</text>
								</paragraph>
                <paragraph id="HED6CC730403D4E819288BA3F36556064">
                  <enum>(2)</enum>
                  <text>to prohibit a
				group health plan or health insurance issuer from requiring prior authorization
				or imposing other appropriate utilization controls in approving coverage for
				any
				chemotherapy.</text>
								</paragraph>
              </subsection>
            </section>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</paragraph>
        <paragraph id="HE064ADC930A148EAB982D245F022F743" indent="up1">
          <enum>(2)</enum>
          <text>
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Employee Retirement Income Security Act of 1974/s:731/ss:c">Section 731(c) of such Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/29/1191/c">29 U.S.C.
			 1191(c)</cato:entity-ref>)</cato:entity> is amended by striking <quote>section 711</quote> and inserting
			 <quote>sections 711 and 716</quote>.</text>
				</paragraph>
        <paragraph id="H5AF2617C44CA4AC4854AF2E53C00FB16" indent="up1">
          <enum>(3)</enum>
          <text>
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Employee Retirement Income Security Act of 1974/s:732/ss:a">Section 732(a) of such Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/29/1191a/a">29 U.S.C.
			 1191a(a)</cato:entity-ref>)</cato:entity> is amended by striking <quote>section 711</quote> and inserting
			 <quote>sections 711 and 716</quote>.</text>
				</paragraph>
        <paragraph id="H065A174D715348A18F6F9EC21E860461" indent="up1">
          <enum>(4)</enum>
          <text>The table of contents in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Employee Retirement Income Security Act of 1974/s:1">section 1 of
			 such Act</cato:entity-ref> is amended by inserting after the item relating to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Employee Retirement Income Security Act of 1974/s:714">section 714</cato:entity-ref> the
			 following new items:</text>
					<quoted-block id="H88CEF95CDED14D5E99C4A3DEE6672D16" style="OLC">
						<toc regeneration="no-regeneration">
							<toc-entry level="section">Sec. 715. Additional market
				reforms.</toc-entry>
							<toc-entry level="section">Sec. 716. Parity in coverage for oral
				anticancer
				drugs.</toc-entry>
						</toc>
						<after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</paragraph>
      </subsection>
      <subsection display-inline="no-display-inline" id="H3013A0D0CFB24B7DB9F610B5815626FF">
        <enum>(b)</enum>
        <header>Public health
			 service act amendments</header>
        <paragraph commented="no" display-inline="yes-display-inline" id="H64018BDD32784179AEEBCCB4B2AA9BF1">
          <enum>(1)</enum>
          <text display-inline="yes-display-inline">
            <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/t:XXVII">Title XXVII of the Public Health Service
			 Act</cato:entity-ref> is amended by inserting after <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Public Health Service Act/s:2728">section 2728</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/300gg-28">42 U.S.C. 300gg–28</external-xref>)</cato:entity>, as
			 redesignated by <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Patient Protection and Affordable Care Act/s:1001/p:2">section 1001(2) of the Patient Protection and Affordable Care
			 Act</cato:entity-ref> (<external-xref legal-doc="public-law" parsable-cite="pl/111/148">Public Law 111–148</external-xref>)</cato:entity>, the following new section:</text>
					<quoted-block id="HF61B547E6A20469997CA5BAE989BC14F" style="OLC">
						<section id="H06FE21AAA32F42D4B71ED7BF5E023065">
              <enum>2729.</enum>
              <header>Parity in
				coverage for oral anticancer drugs</header>
							<subsection display-inline="no-display-inline" id="H16EEF67B9D4C459BA71515ACCD798586">
                <enum>(a)</enum>
                <header>In
				general</header>
                <text display-inline="yes-display-inline">Subject to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2729/ss:b" proposed="true">subsection
				(b)</cato:entity-ref>, a group health plan, and a health insurance issuer offering health
				insurance coverage, that provides benefits with respect to anticancer
				medications administered by a health care provider shall provide for no less
				favorable coverage for prescribed, patient-administered anticancer medications
				that are used to kill, slow, or prevent the growth of cancerous cells and that
				have been approved by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref>.</text>
							</subsection>
              <subsection commented="no" id="H9AF2164BC45446D2ADBEBA9FF4FE7137">
                <enum>(b)</enum>
                <header>Limitation</header>
                <text>
                  <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2729/ss:a" proposed="true">Subsection
				(a)</cato:entity-ref> shall only apply to an anticancer medication that is prescribed based on a
				finding by the treating physician that the medication—</text>
								<paragraph commented="no" id="H6EF99367822940AAB80990AB2D5C1245">
                  <enum>(1)</enum>
                  <text>is medically
				necessary for the purpose of killing, slowing, or preventing the growth of
				cancerous cells; or</text>
								</paragraph>
                <paragraph commented="no" id="HA2F853B70B724150829F8DAF2A86EAA0">
                  <enum>(2)</enum>
                  <text>is clinically
				appropriate in terms of type, frequency, extent site, and duration.</text>
								</paragraph>
              </subsection>
              <subsection id="HF8249A070B814093B102AF345DDF0DEB">
                <enum>(c)</enum>
                <header>Application of
				cost-Sharing and restrictions</header>
								<paragraph id="HD1AD4F6F5A7241A0818018F679E928C1">
                  <enum>(1)</enum>
                  <header>In
				general</header>
                  <text display-inline="yes-display-inline">The coverage of
				anticancer medication under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2729/ss:a" proposed="true">subsection (a)</cato:entity-ref> may be subject to annual deductibles
				and coinsurance or copayments so long as such deductibles, coinsurance, and
				copayments do not exceed the deductibles, coinsurance, and copayments that are
				applicable to anticancer medications administered by a health care provider
				under the plan or coverage for the same purpose.</text>
								</paragraph>
                <paragraph commented="no" id="HE8A7FF98FDFD42C3B5EC44E38EE6A21B">
                  <enum>(2)</enum>
                  <header>Restriction</header>
                  <text display-inline="yes-display-inline">A group health plan or health insurance
				issuer may not, in order to comply with the requirement of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2729/ss:a" proposed="true">subsection
				(a)</cato:entity-ref>—</text>
									<subparagraph commented="no" id="HB78BD5A6B3F24C8F9E6A965901950436">
                    <enum>(A)</enum>
                    <text>impose an increase
				in out-of-pocket costs with respect to anticancer medications;</text>
									</subparagraph>
                  <subparagraph commented="no" id="H1BBF97F9C4364458B2F1FEE9078E3947">
                    <enum>(B)</enum>
                    <text display-inline="yes-display-inline">reclassify benefits with respect to
				anticancer medications; or</text>
									</subparagraph>
                  <subparagraph id="H5C70F80CB9EE4870AFCA37CEB4AFB1CB">
                    <enum>(C)</enum>
                    <text>apply more
				restrictive limitations on prescribed orally-administered anticancer
				medications or intravenously administered or injected anticancer
				medications.</text>
									</subparagraph>
                </paragraph>
              </subsection>
              <subsection id="HCE6B810A25FA4FAAA3AA1C3BA5F7C637">
                <enum>(d)</enum>
                <header>Application of
				notice, prohibitions, etc</header>
                <text display-inline="yes-display-inline">The
				provisions of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Employee Retirement Income Security Act of 1974/s:713/ss:b">subsections (b)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Employee Retirement Income Security Act of 1974/s:713/ss:c">(c)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Employee Retirement Income Security Act of 1974/s:713/ss:d">(d)</cato:entity-ref>, and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Employee Retirement Income Security Act of 1974/s:713/ss:e/p:2">(e)(2) of section 713 of the
				Employee Retirement and Income Security Act of 1974</cato:entity-ref> shall apply with respect to
				the coverage required by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2729/ss:a" proposed="true">subsection (a)</cato:entity-ref> in the same manner as they apply with
				respect to the coverage required under such section, except that January 1,
				2014, shall be substituted for the date referred to in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2729/ss:b/p:3" proposed="true">subsection (b)(3) of
				such section</cato:entity-ref>.</text>
							</subsection>
              <subsection id="H7F9F404C5CDC4E488A22B25BA4EED4EA">
                <enum>(e)</enum>
                <header>Construction</header>
                <text>Nothing
				in this section shall be construed—</text>
								<paragraph id="H1ED71A87E7254C4297C9DD9818C14285">
                  <enum>(1)</enum>
                  <text display-inline="yes-display-inline">to require the use of orally-administered
				anticancer medications as a replacement for other anticancer medications;
				or</text>
								</paragraph>
                <paragraph id="H61ABE0EA1C42486DB160827D3D6C0BFF">
                  <enum>(2)</enum>
                  <text>to prohibit a
				group health plan or health insurance issuer from requiring prior authorization
				or imposing other appropriate utilization controls in approving coverage for
				any
				chemotherapy.</text>
								</paragraph>
              </subsection>
            </section>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</paragraph>
        <paragraph id="H7B6A778707F54025AA4C2BC893EACF89" indent="up1">
          <enum>(2)</enum>
          <text>
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Public Health Service Act/s:2724/ss:c">Section 2724(c) of such Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/42/300gg–23/c">42
			 U.S.C. 300gg–23(c)</cato:entity-ref>)</cato:entity>, as redesignated by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="public-law" value="public-law/111/148/s:1001/p:4">section 1001(4)</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="public-law" value="public-law/111/148/s:1563/ss:c/p:14">subsection (c)(14)
			 of the section 1563</cato:entity-ref> (relating to conforming amendments) of <external-xref legal-doc="public-law" parsable-cite="pl/111/148">Public Law 111–148</external-xref>,
			 is amended by striking <quote>section 2704</quote> and inserting
			 <quote>sections 2725 and 2729</quote>.</text>
				</paragraph>
        <paragraph id="H008FEAAFC6F2418BBE85E4884A0890CD" indent="up1">
          <enum>(3)</enum>
          <text>
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Public Health Service Act/s:2762/ss:b/p:2">Section 2762(b)(2) of such Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/42/300gg–62/b/2">42
			 U.S.C. 300gg–62(b)(2)</cato:entity-ref>)</cato:entity> is amended by striking <quote>section 2751</quote> and
			 inserting <quote>sections 2751 and 2729</quote>.</text>
				</paragraph>
        <paragraph id="H04AF981DFBDE4502B4E1554F4B71754D" indent="up1">
          <enum>(4)</enum>
          <text display-inline="yes-display-inline">For purposes of applying <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2729" proposed="true">section 2729 of
			 the Public Health Service Act</cato:entity-ref>, as inserted by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Cancer Drug Coverage Parity Act of 2013/s:2/ss:b/p:1" proposed="true">paragraph (1)</cato:entity-ref>, to individual
			 health insurance coverage before 2014, the provisions of such section shall be
			 treated as also included under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/t:XXVII/pt:B">part B of title XXVII of the Public Health
			 Service Act</cato:entity-ref>.</text>
				</paragraph>
      </subsection>
      <subsection id="H06ABD7D7DF4643B7A960113EAF9D5293">
        <enum>(c)</enum>
        <header>Internal revenue
			 code amendments</header>
				<paragraph id="HF940F8A31E3D4C1C861CC593B9B2418C">
          <enum>(1)</enum>
          <header>In
			 general</header>
          <text>
            <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/ch:100/sch:B">Subchapter B of chapter 100 of the Internal Revenue Code
			 of 1986</cato:entity-ref>, as amended by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="public-law" value="public-law/111/148/s:1563/ss:f">subsection (f) of the section 1563</cato:entity-ref> (relating to
			 conforming amendments) of <external-xref legal-doc="public-law" parsable-cite="pl/111/148">Public Law 111–148</external-xref>, is amended by adding at the end
			 the following new section:</text>
					<quoted-block display-inline="no-display-inline" id="H9AF9DA072509449992A4ED28BD46DF3C" style="OLC">
						<section id="H5FE28C5F44B64BA999F8DCD872A5911D">
              <enum>9816.</enum>
              <header>Parity in
				coverage for oral anticancer drugs</header>
							<subsection id="H6728323FDC6C4077A568EDF060949BCE">
                <enum>(a)</enum>
                <header>In
				general</header>
                <text display-inline="yes-display-inline">Subject to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:9816/ss:b" proposed="true">subsection
				(b)</cato:entity-ref>, a group health plan that provides benefits with respect to anticancer
				medications administered by a health care provider shall provide for no less
				favorable coverage for prescribed, patient-administered anticancer medications
				that are used to kill, slow, or prevent the growth of cancerous cells and that
				have been approved by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref>.</text>
							</subsection>
              <subsection commented="no" id="H3247223A703747F08D8FB2669A4D3D0C">
                <enum>(b)</enum>
                <header>Limitation</header>
                <text>
                  <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:9816/ss:a" proposed="true">Subsection
				(a)</cato:entity-ref> shall only apply to an anticancer medication that is prescribed based on a
				finding by the treating physician that the medication—</text>
								<paragraph commented="no" id="HE2C7F240407D4B72964743DCFEB719DE">
                  <enum>(1)</enum>
                  <text>is medically
				necessary for the purpose of killing, slowing, or preventing the growth of
				cancerous cells; or</text>
								</paragraph>
                <paragraph commented="no" id="H7A8CF8433FB041E5B6F99058760B4365">
                  <enum>(2)</enum>
                  <text>is clinically
				appropriate in terms of type, frequency, extent site, and duration.</text>
								</paragraph>
              </subsection>
              <subsection id="H62C8A5B61E6840B298F836C04F2BF716">
                <enum>(c)</enum>
                <header>Application of
				cost-Sharing and restrictions</header>
								<paragraph id="H3DCEEF1704C640838B76B0A848812CDE">
                  <enum>(1)</enum>
                  <header>In
				general</header>
                  <text display-inline="yes-display-inline">The coverage of
				anticancer medication under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:9816/ss:a" proposed="true">subsection (a)</cato:entity-ref> may be subject to annual deductibles
				and coinsurance or copayments so long as such deductibles, coinsurance, and
				copayments do not exceed the deductibles, coinsurance, and copayments that are
				applicable to anticancer medications administered by a health care provider
				under the plan for the same purpose.</text>
								</paragraph>
                <paragraph commented="no" id="H87278E0FD73C4E51A61B38EB9804F60A">
                  <enum>(2)</enum>
                  <header>Restriction</header>
                  <text display-inline="yes-display-inline">A group health plan may not, in order to
				comply with the requirement of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:9816/ss:a" proposed="true">subsection (a)</cato:entity-ref>—</text>
									<subparagraph commented="no" id="H895BB0C7640E460C861C686D0BF48300">
                    <enum>(A)</enum>
                    <text>impose an increase
				in out-of-pocket costs with respect to anticancer medications;</text>
									</subparagraph>
                  <subparagraph commented="no" id="HA81F1C52C36840D9A2617EC14CFA81F1">
                    <enum>(B)</enum>
                    <text display-inline="yes-display-inline">reclassify benefits with respect to
				anticancer medications; or</text>
									</subparagraph>
                  <subparagraph id="H634F7285C7374FC6970B73D08876E9B3">
                    <enum>(C)</enum>
                    <text>apply more
				restrictive limitations on prescribed orally-administered anticancer
				medications or intravenously administered or injected anticancer
				medications.</text>
									</subparagraph>
                </paragraph>
              </subsection>
              <subsection id="H4E2532B6E1CC44A1935FADFA0B9CF762">
                <enum>(d)</enum>
                <header>Application of
				notice, prohibitions, etc</header>
                <text>The provisions of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Employee Retirement Income Security Act of 1974/s:713/ss:b">subsections (b)</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Employee Retirement Income Security Act of 1974/s:713/ss:c">(c)</cato:entity-ref>,
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Employee Retirement Income Security Act of 1974/s:713/ss:d">(d)</cato:entity-ref>, and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Employee Retirement Income Security Act of 1974/s:713/ss:e/p:2">(e)(2) of section 713 of the Employee Retirement and Income Security
				Act of 1974</cato:entity-ref> shall apply with respect to the coverage required by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:9816/ss:a" proposed="true">subsection (a)</cato:entity-ref>
				in the same manner as they apply with respect to the coverage required under
				such section, except that January 1, 2014, shall be substituted for the date
				referred to in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Internal Revenue Code of 1986/s:9816/ss:b/p:3" proposed="true">subsection (b)(3) of such section</cato:entity-ref>.</text>
							</subsection>
              <subsection id="H2682627B6B744686845C2E79E5EEEB9F">
                <enum>(e)</enum>
                <header>Construction</header>
                <text>Nothing
				in this section shall be construed—</text>
								<paragraph id="H79E1961AE5384E5C9FD145EB9230ED57">
                  <enum>(1)</enum>
                  <text display-inline="yes-display-inline">to require the use of orally-administered
				anticancer medications as a replacement for other anticancer medications;
				or</text>
								</paragraph>
                <paragraph id="H80E99E36134448AF8267F34AA99551A1">
                  <enum>(2)</enum>
                  <text>to prohibit a
				group health plan or health insurance issuer from requiring prior authorization
				or imposing other appropriate utilization controls in approving coverage for
				any
				chemotherapy.</text>
								</paragraph>
              </subsection>
            </section>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</paragraph>
        <paragraph id="HF2D9F4653C1E4C309C93BAD3DCA04A1E">
          <enum>(2)</enum>
          <header>Clerical
			 amendment</header>
          <text>The table of sections for such subchapter is amended by
			 adding at the end the following new items:</text>
					<quoted-block id="H66DE41722CDD4E16962FD9B6832D4CDC" style="OLC">
						<toc regeneration="no-regeneration">
							<toc-entry level="section">Sec. 9815. Additional market
				reforms.</toc-entry>
							<toc-entry level="section">Sec. 9816. Parity in coverage for oral
				anticancer
				drugs.</toc-entry>
						</toc>
						<after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</paragraph>
      </subsection>
      <subsection display-inline="no-display-inline" id="H933B683720F741AC92B2F96FA318EDE9">
        <enum>(d)</enum>
        <header>Clarifying
			 amendment regarding application to grandfathered plans</header>
        <text display-inline="yes-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Patient Protection and Affordable Care Act/s:1251/ss:a/p:4/sp:A">Section 1251(a)(4)(A) of the Patient
			 Protection and Affordable Care Act</cato:entity-ref> (<external-xref legal-doc="public-law" parsable-cite="pl/111/148">Public Law 111–148</external-xref>; <cato:entity-ref entity-type="uscode" value="usc/42/18011/a/4/A">42 U.S.C.
			 18011(a)(4)(A)</cato:entity-ref>)</cato:entity>, as added by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="public-law" value="public-law/111/152/s:2301/ss:a">section 2301(a) of <external-xref legal-doc="public-law" parsable-cite="pl/111/152">Public Law 111–152</external-xref>
          </cato:entity-ref>, is amended
			 by adding at the end the following new clause:</text>
				<quoted-block display-inline="no-display-inline" id="H33D1B4EA97B84E789A8279763AE9AA86" style="OLC">
					<clause id="H71F75B1DC4864FA090D53B14A1222939">
            <enum>(v)</enum>
            <text display-inline="yes-display-inline">
              <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2729" proposed="true">Section 2729</cato:entity-ref>, as added by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Cancer Drug Coverage Parity Act of 2013/s:2/ss:b" proposed="true">section 2(b) of
				the <short-title>Cancer Drug Coverage Parity Act of
				2013</short-title>
              </cato:entity-ref>.</text>
					</clause>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</subsection>
      <subsection id="H116AAD2BD27341F0BB3CA7A4B0E1E460">
        <enum>(e)</enum>
        <header>Effective
			 date</header>
        <text display-inline="yes-display-inline">The amendments made by
			 this section shall apply with respect to group health plans for plan years
			 beginning on or after January 1, 2014, and with respect to health insurance
			 coverage offered, sold, issued, renewed, in effect, or operated in the
			 individual market on or after such date.</text>
			</subsection>
      <subsection id="HD79329F22A6F487F916E2AE19B19B5E4">
        <enum>(f)</enum>
        <header>Study</header>
        <text display-inline="yes-display-inline">Not later than 2 years after the date of
			 the enactment of this Act—</text>
				<paragraph id="HB465D2F51B3844EABD079D2C71FF4D55">
          <enum>(1)</enum>
          <text>the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="4835">Medicare
			 Payment Advisory Commission</cato:entity-ref> shall complete a study that assesses how closing
			 the Medicare part D donut hole under the amendments made by <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Patient Protection and Affordable Care Act/s:3301">section 3301 of the
			 Patient Protection and Affordable Care Act</cato:entity-ref> (<external-xref legal-doc="public-law" parsable-cite="pl/111/148">Public Law 111–148</external-xref>)</cato:entity>, as amended by
			 <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Health Care and Education Reconciliation Act of 2010/s:1101">section 1101 of the Health Care and Education Reconciliation Act of 2010</cato:entity-ref>
			 (<external-xref legal-doc="public-law" parsable-cite="pl/111/152">Public Law 111–152</external-xref>)</cato:entity>, affects Medicare coverage for orally administered
			 anticancer medications, with a particular focus on cost and accessibility;
			 and</text>
				</paragraph>
        <paragraph id="H0BEA5B219AF441ED8AFC47882651CD3C">
          <enum>(2)</enum>
          <text>submit a report to
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> on the results of such study.</text>
				</paragraph>
      </subsection>
    </section>
  </legis-body>
</bill>
</doc>